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LETTERS TO THE EDITOR
Protection Factors are Ratios
To the Editor:
In their abstract, Davenport et al (1997) state that ‘‘Results consistently
demonstrated that all the test sunscreens protected (against immunosup-
pression) beyond their designated protections factors.’’ Protection factors
are ratios by definition, and if the above statement by Davenport et al
(1997) means anything at all, it is that the sunscreens’ immune protection
factors were greater than their corresponding sun protection factors
(SPF). Chu et al (1998) restate their claim in their recent letter to the
Journal of Investigative Dermatology in which they also state that they did
not calculate immune protection factors in their original paper but would
have to concede, from their own data, that had they done so, as suggested
in letters by Gasparro (1998) and Wolf and Kripke (1998), these would
have been lower than the corresponding SPF. If the immune protection
factor is lower than the SPF, it is just not possible for sunscreens ‘‘to
protect beyond their designated protection factors.’’ The authors tested
products with SPF ranging from 3.6 to 5.7, and defend their original
conclusions by arguing that although ex vivo skin exposed to 5 minimal
erythema doses (MED) results in 50% immunosuppression, a sunscreen
of SPF 5 5 completely protects against immunosuppression when skin
is exposed to 5 MED. This is hardly surprising as 5 MED with an SPF of
5 is equivalent to 1 MED without a sunscreen, and 1 MED without
sunscreen almost certainly does not cause immunosuppression in their
model. All the authors can conclude from this analysis is that 1 MED
delivered to the skin, with or without sunscreen, is not immunosuppres-
sive. Furthermore, the UV dose-threshold for immunosuppression in
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PUVA Therapy and Human Papillomavirus Type 5 Detection in
Psoriasis
To the Editor:
Michel Favre et al reported in this Journal a high prevalence of human
papillomavirus 5 (HPV5) infection in psoriatic patients and proposed that
psoriasis is a reservoir for this virus (Favre et al, 1998). These conclusions
were based on (i) the presence of antibodies against HPV5 VLP in 24.5%
of 155 psoriatic patients, contrasting with the 2%–5% observed in the
two other groups (atopic dermatitis and renal transplant recipients); (ii)
the detection of HPV5 DNA sequences by nested polymerase chain
reaction in lesional and uninvolved skin of 91.9% psoriatic patients and
in no patient in the atopic dermatitis group, respectively.
These results are very exciting but we question whether the high
prevalence of HPV5 infection is related to the psoriasis itself or to a
possible irradiation with ultraviolet (UV) via phototherapy. Indeed,
Bayle-Lebey et al have already reported the detection of HPV5 DNA
sequences in a keratosic skin lesion in a psoriatic patient, although this
patient had been treated for a long time with UVA phototherapy (Bayle-
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their in vitro assay is at least 3 MED. Therefore any sunscreen that protects
against erythema will protect against immunosuppression if tested using
their model. In order to evaluate an endpoint, one has to give a UVR
dose (with and without sunscreen) that induces the endpoint (e.g., 50%
immunosuppression). For example, it would be impossible to assess SPF
without giving an erythemal dose. In their recent letter, Chu et al express
concern about the possibility of sunscreens giving better protection
against erythema than immunosuppression, but the only way to evaluate
this legitimate concern is to compare immune protection factor with
SPF. Any conclusions on photoprotection (of any endpoint) without the
use of ratios will depend on the sensitivity of the assay and are therefore
invalid. In this context, it is worth stating that the SPF of the products
tested were determined in vitro and it is well known that such determina-
tions do not necessarily accord with in vivo assessments.
In summary, we totally agree with the letters by Gasparro (1998) and
Wolf and Kripke (1998), that the data of Davenport et al (1997) do not
show that sunscreens protect against immunosuppression beyond their
designated protection factors; in fact their data show exactly the opposite.
Antony Young, Susan L. Walker
Department of Photobiology, St John’s Institute of Dermatology, St
Thomas’s Hospital, London, U.K.
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Lebey et al, 1994). Unfortunately, data on the previous treatments of
Favre psoriatic patients are unknown. Moreover, the reported detection
ofHPVDNAsequences inboth involved andnonlesional skin inpsoriatic
patients suggests the role of an extrinsic factor such as UV.
The role of UV in epidermodysplasia verruciformis (EV) is well known
(Orth, 1987), and excessive sun exposure is avoided in EV patients.
Pityriasis versicolor-like skin lesions observed in EV and associated with
HPV infection are particularly located in sun-exposed areas. The role of
UV is clearly demonstrated in the induction of HPV5-associated skin
carcinomas in EV and in renal transplant recipients.
Few data are available concerning the search of EV-associated HPV
infection in patients under phototherapy. Spradbrow et al reported the
presence of a possible papillomavirus in sun-exposed skin (Spradbrow
et al, 1983); but most reported data are related to HPV16.
UV may act either via a local immunosuppression that could facilitate
HPV DNA replication, or transcription of HPV. It can be hypothesized
that EV-related HPV are widespread and that some factors such as local
(UV) or general immunosuppression (EV, immunosuppressive agents,
AIDS) may facilitate their replication and/or persistence.
On the other hand, it is difficult to understand the general good
efficiency of phototherapy in psoriatic patients and its detrimental effect
